Forbes

Cameron Health's Subcutaneous ICD Sails Through FDA Advisory Panel

The FDA’s Circulatory System Devices panel voted 7-1 on Thursday that the benefits of the Cameron Health subcutaneous ICD system (S-ICD) outweigh the risks in appropriately selected patients. The ...
Medscape

Life-span of First-Generation S-ICD Is 5 Years, Study Reports

ROTTERDAM, THE NETHERLANDS — Researchers have determined that on average, the first-generation subcutaneous implantable cardioverter defibrillator S-ICD (Boston Scientific and formerly Cameron Health) ...
Yahoo Finance

Medtronic’s Aurora EV-ICD to challenge Boston Scientific’s S-ICD market leadership

Medtronic’s recent FDA-approved Aurora Extravascular Implantable Cardioverter Defibrillator (EV-ICD) is poised to revolutionise the cardiac device market. This device, which places leads outside both ...
MD&M East

Boston Scientific's Subcutaneous-ICD Gets a Boost

Boston Scientific's Emblem S-ICD, the next generation subcutaneous ICD product, is a novel technology that removes what many believe is the weakest link in implantable cardioverter defibrillators - ...
TCTMD

Fewer Lead-Related Complications With Subcutaneous ICD: ATLAS S-ICD

SAN FRANCISCO, CA—The subcutaneous implantable cardioverter-defibrillator (S-ICD; Boston Scientific) prevents most of the major lead-related complications seen with a transvenous system, the ATLAS ...
Forbes

Subcutaneous ICD Gains FDA Approval

The FDA today approved the Subcutaneous Implantable Defibrillator (S-ICD) system from Cameron Health. The device is the first ICD that does not require a lead that connects directly to the heart and ...
Nasdaq

FDA Approves Boston Scientific's Emblem MRI S-ICD System

The U.S. Food and Drug Administration (FDA) recently granted marketing approval for Boston Scientific Corporation 's BSX Emblem MRI Subcutaneous Implantable Defibrillator (S-ICD) System, in line with ...
Healio

Subcutaneous ICD reduces rate of major lead-related complications: ATLAS

Please provide your email address to receive an email when new articles are posted on . Among patients who received implantable cardioverter defibrillator therapy, a subcutaneous vs. transvenous ...
EurekAlert!

Implantation of an S-ICD in a patient with a DDD pacemaker and congenitally corrected transposition

Implantation of an S-ICD in a Patient with a DDD Pacemaker and Congenitally Corrected Transposition of the Great Arteries In a new publication from Cardiovascular ...
News Medical

Researchers report a case of S-ICD implantation in patient with ccTGA and DDD pacemaker

In a new publication from Cardiovascular Innovations and Applications; Yu Zhang, Wen-Long Dai, Can-Can Lin, Qiao-Yuan Li and Cheng-Jun Guo from Beijing Anzhen Hospital, Capital Medical University, ...
Medscape

FDA approves first subcutaneous ICD

Silver Spring, MD - As expected, the S-ICD (Cameron Health/Boston Scientific) has become the first subcutaneous implantable cardioverter defibrillator available commercially in the US after the Food ...